Literature DB >> 28291188

Quantification of Peri-Implant Bacterial Load and in Vivo Biofilm Formation in an Innovative, Clinically Representative Mouse Model of Periprosthetic Joint Infection.

Alberto V Carli1, Samrath Bhimani, Xu Yang, Matthew B Shirley, Karen L de Mesy Bentley, F Patrick Ross, Mathias P G Bostrom.   

Abstract

BACKGROUND: Periprosthetic joint infection (PJI) is a devastating complication following total joint arthroplasty. Current animal models of PJI are limited because of a lack of quantitative methods and failure to effectively recreate the periprosthetic space. We therefore developed a murine PJI model involving a 3-dimensionally printed Ti-6Al-4V implant capable of bearing weight and permitting quantitative analysis of periprosthetic bacterial load and evaluation of biofilm.
METHODS: Twenty-five 12-week-old C57BL/6 mice received a unilateral proximal tibial implant and intra-articular injection of either 3 × 10 colony forming units (CFUs) of Staphylococcus aureus Xen 36 or saline solution. Postoperatively, mice underwent gait analysis, knee radiographs, and serum inflammatory marker measurements. Following euthanasia at 2 or 6 weeks, bone and soft tissues were homogenized to quantify bacteria within periprosthetic tissues. Implants were either sonicated to quantify adherent bacteria or examined under scanning electron microscopy (SEM) to characterize biofilm.
RESULTS: All mice survived surgery and were not systemically septic. The control mice immediately tolerated weight-bearing and had normal inflammatory markers and radiographic signs of osseointegration. Infected mice had difficulty walking over time, exhibited radiographic findings of septic implant loosening, and had significantly elevated inflammatory markers. Periprosthetic tissues of the infected animals displayed a mean of 4.46 × 10 CFUs of S. aureus at 2 weeks and 2.53 × 10 CFUs at 6 weeks. Viable S. aureus was quantified on retrieved implant surfaces. SEM demonstrated S. aureus cocci in clusters encased within biofilm.
CONCLUSIONS: This animal model is, to our knowledge, the most clinically representative PJI replication to date. It is the first that we know of to produce infection through the same method hypothesized to occur clinically, utilize a weight-bearing implant that can osseointegrate, and provide quantitative data on 8 aspects of PJI, including radiographic features, inflammatory markers, and bacterial loads. CLINICAL RELEVANCE: This novel animal model is, to our knowledge, the first to provide a load-bearing translational representation of clinical PJI that effectively recreates the periprosthetic space.

Entities:  

Mesh:

Year:  2017        PMID: 28291188     DOI: 10.2106/JBJS.16.00815

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  18 in total

1.  CORR Insights®: Single-stage Acetabular Revision During Two-stage THA Revision for Infection is Effective in Selected Patients.

Authors:  Dror Lakstein
Journal:  Clin Orthop Relat Res       Date:  2017-04-25       Impact factor: 4.176

2.  Disruption of the Gut Microbiome Increases the Risk of Periprosthetic Joint Infection in Mice.

Authors:  Christopher J Hernandez; Xu Yang; Gang Ji; Yingzhen Niu; Arvinth S Sethuraman; Joseph Koressel; Matthew Shirley; Michael W Fields; Susan Chyou; Thomas M Li; Marysol Luna; Rowan L Callahan; F Patrick Ross; Theresa T Lu; Ilana L Brito; Alberto V Carli; Mathias P G Bostrom
Journal:  Clin Orthop Relat Res       Date:  2019-11       Impact factor: 4.176

3.  3D printing in experimental orthopaedic surgery: do it yourself.

Authors:  Irene I López-Torres; Pablo Sanz-Ruíz; Victor E León-Román; Federico Navarro-García; Rodrigo Priego-Sánchez; Javier Vaquero-Martín
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-03-12

4.  Immune Response to Persistent Staphyloccocus Aureus Periprosthetic Joint Infection in a Mouse Tibial Implant Model.

Authors:  Upneet K Sokhi; Yunwei Xia; Branden Sosa; Kathleen Turajane; Sita N Nishtala; Tania Pannellini; Mathias P Bostrom; Alberto V Carli; Xu Yang; Lionel B Ivashkiv
Journal:  J Bone Miner Res       Date:  2022-01-03       Impact factor: 6.741

Review 5.  Biofilms: Formation, Research Models, Potential Targets, and Methods for Prevention and Treatment.

Authors:  Yajuan Su; Jaime T Yrastorza; Mitchell Matis; Jenna Cusick; Siwei Zhao; Guangshun Wang; Jingwei Xie
Journal:  Adv Sci (Weinh)       Date:  2022-08-28       Impact factor: 17.521

6.  Mouse model of Gram-negative prosthetic joint infection reveals therapeutic targets.

Authors:  John M Thompson; Robert J Miller; Alyssa G Ashbaugh; Carly A Dillen; Julie E Pickett; Yu Wang; Roger V Ortines; Robert S Sterling; Kevin P Francis; Nicholas M Bernthal; Taylor S Cohen; Christine Tkaczyk; Li Yu; C Kendall Stover; Antonio DiGiandomenico; Bret R Sellman; Daniel Lj Thorek; Lloyd S Miller
Journal:  JCI Insight       Date:  2018-09-06

Review 7.  Current Options and Emerging Biomaterials for Periprosthetic Joint Infection.

Authors:  Ashley E Levack; Erika L Cyphert; Mathias P Bostrom; Christopher J Hernandez; Horst A von Recum; Alberto V Carli
Journal:  Curr Rheumatol Rep       Date:  2018-04-30       Impact factor: 4.592

8.  Musculoskeletal Microbiology: The Microbiome in Orthopaedic Biomechanics.

Authors:  Christopher J Hernandez
Journal:  Curr Opin Biomed Eng       Date:  2021-05-06

9.  In Vivo Bioluminescence Imaging in a Rabbit Model of Orthopaedic Implant-Associated Infection to Monitor Efficacy of an Antibiotic-Releasing Coating.

Authors:  Robert J Miller; John M Thompson; Jesse Zheng; Mark C Marchitto; Nathan K Archer; Bret L Pinsker; Roger V Ortines; Xuesong Jiang; Russell A Martin; Isabelle D Brown; Yu Wang; Robert S Sterling; Hai-Quan Mao; Lloyd S Miller
Journal:  J Bone Joint Surg Am       Date:  2019-02-20       Impact factor: 5.284

10.  Local Application of Vancomycin in One-Stage Revision of Prosthetic Joint Infection Caused by Methicillin-Resistant Staphylococcus aureus.

Authors:  Jian Wei; Yinxian Wen; Kai Tong; Hui Wang; Liaobin Chen
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.